Ranbaxy Laboratories Limited (Ranbaxy) is a research based international pharmaceutical company serving customers in over 150 countries. For more than 50 years, we have been providing high quality, affordable medicines trusted by healthcare professionals and patients across geographies.
Read More

Worldwide Presence

Update on Atorvastatin Recall in USA

On March 26, 2013, Ranbaxy Pharmaceuticals Inc., the U.S. subsidiary of Ranbaxy Laboratories Limited, resumed the supply of Atorvastatin calcium tablets that includes...
Read More

Explore Ranbaxy

Latest News

Ranbaxy Announces Conclusion Of Previously Disclosed Investigation By U.S. Department Of Justice
May 13, 2013: Ranbaxy Laboratories Ltd. (RLL, NSE: RANBAXY, BSE: 500359) (“Ranbaxy”), today announced that a previously disclosed investigation by the U.S. Department…
Edit
Ranbaxy Q1 CY 2013 Sales Rs.24,398 Mn. Base business grows by over 10%
May 08, 2013: Focus continues in branded markets and differentiated products The Board of Directors of Ranbaxy Laboratories Limited (RLL, NSE: RANBAXY, BSE:…
Edit
Daiichi Sankyo and Ranbaxy launch hybrid business in Brazil to expand business of both companies
Apr 17, 2013: Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and Ranbaxy Laboratories Limited (hereafter, Ranbaxy) today announced synergy in Brazil to expand…
Edit
Ranbaxy to market Desvenlafaxine Base Extended Release Tablets in The U.S.
Mar 05, 2013: Enters into an in-licensing business agreement with Alembic Princeton, NJ – March 05, 2013 — Ranbaxy Pharmaceuticals Inc. (RPI), a…
Edit
RANBAXY SURPASS 2012 GUIDANCE; CROSSES RS.120 BN IN GLOBAL SALES
Feb 26, 2013: Q4 CY 2012 Sales Rs.26,708 Mn CY 2012 Sales Rs.123 Bn, EBITDA Rs.18,227 Mn EBITDA margin 15%. Sales growth of…
Edit
DAIICHI SANKYO AND RANBAXY TO LEVERAGE SYNERGIES IN THAILAND
Jan 16, 2013: Daiichi Sankyo Company, Limited (Daiichi Sankyo) and Ranbaxy Laboratories Limited (Ranbaxy) today announced their intention to integrate their business operations…
Edit
RANBAXY LAUNCHES ABSORICA™ (ISOTRETINOIN) CAPSULES IN THE U.S. HEALTHCARE MARKET
Nov 26, 2012: Ranbaxy Laboratories, Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), today announced the sales and promotion launch…
Edit
RANBAXY DELIVERS STRONG OVERALL BUSINESS PERFORMANCE; IMPROVEMENT IN BASE BUSINESS SALES AND MARGINS
Nov 08, 2012: Q3 CY 2012 Sales Rs.26,514 Mn ($480 Mn), EBITDA Rs.4,179 Mn ($76 Mn) EBITDA margin 16%; Sales growth of 31%…
Edit